Remove Invention Remove Licensing Remove Litigation Remove Webinar
article thumbnail

Monday Miscellany

The IPKat

In this webinar, Sir Robin and Dheemanth will explore the requirement’s origins, how it has been applied by EPO and the English courts in recent years, and what they envisage for the requirement’s future. Webinar - The "Taylor’s Version Strategy" or re-recording music albums: (legally) possible in EU too? (13 To sign up, click here.

article thumbnail

Time to look Beyond Compulsory Licenses? A Glimpse at the Ribociclib Case

SpicyIP

Image from here Recently, the Print reported that Novartis and Eli Lilly have voiced their opposition to the idea of compulsory licensing (“ CL ”) for breast cancer medications, Ribociclib and Abemaciclib. It also says that no licenses were given out. The patented invention is not available at a reasonably affordable price.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sunday Surprises

The IPKat

Webinars Two webinars will be organised by 4IPcouncil as a part of its September and October activities: SEP Regulation: proposed mechanisms in determining a reasonable aggregate royalty on September 28, delivered by Dr. The event will be held on September 20, 2023 in London.

article thumbnail

IP and Cannabis: The Current Landscape

Fish & Richardson Trademark & Copyright Thoughts

For more information about any topic herein, please see our October 20, 2020 webinar, “ IP and Cannabis: The Current Landscape ,” or contact your Fish attorney. Unlike trademark registrations, there is no requirement that a patent applicant demonstrate that it has used the claimed invention in commerce. Patent Litigation.

IP 52
article thumbnail

White House Directs Copyright Office and USPTO to Provide Guidance on AI-Related Issues

Trading Secrets

Specifically: AI Inventorship: The Executive Order mandates the USPTO Director to publish, by the end of February 2024, guidance to the USPTO’s patent examiners and applicants addressing inventorship and the utilization of AI, including generative AI, in the inventive process. See our prior post on issues raised by Thaler.

article thumbnail

White House Directs Copyright Office and USPTO to Provide Guidance on AI-Related Issues

LexBlog IP

Specifically: AI Inventorship: The Executive Order mandates the USPTO Director to publish, by the end of February 2024, guidance to the USPTO’s patent examiners and applicants addressing inventorship and the utilization of AI, including generative AI, in the inventive process. See our prior post on issues raised by Thaler.

article thumbnail

White House Directs Copyright Office and USPTO to Provide Guidance on AI-Related Issues

LexBlog IP

Specifically: AI Inventorship: The Executive Order mandates the USPTO Director to publish, by the end of February 2024, guidance to the USPTO’s patent examiners and applicants addressing inventorship and the utilization of AI, including generative AI, in the inventive process. See our prior post on issues raised by Thaler.